NIMODIPINE vs NIRSEVIMAB-ALIP: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIMODIPINE vs NIRSEVIMAB-ALIP: Safety Overview
| Metric | NIMODIPINE | NIRSEVIMAB-ALIP |
|---|---|---|
| Total FAERS Reports | 416 | 783 |
| Deaths Reported | 32 | 32 |
| Death Rate | 7.7% | 4.1% |
| Hospitalizations | 158 | 281 |
| Average Patient Age | 53.9 yrs | 3.3 yrs |
| % Female Patients | 62.3% | 46.3% |
| FDA Approval Date | Apr 17, 2007 | N/A |
| Manufacturer | Heritage Pharmaceuticals Inc. d/b/a A... | N/A |
| Route | ORAL | N/A |
| Marketing Status | Discontinued | Prescription |